https://www.selleckchem.com/pr....oducts/epacadostat-i
41-6.5), time to developing ERF from diagnosis (greater than vs within 3 months, HR=5.82 (1.84-18.36)) and location of ERF (distal vs proximal, HR=2.47 (1.14-5.34)) had a significant impact on F-OS. The comparative efficacy (OS and F-OS) of best supportive care was statistically equivalent to any intervention irrespective of AJCC stage and success/failure of initial or subsequent intervention(s). The survival of patients with ERF is dismal, and our analysis suggests that best supportive care results in equivalent OS and
Like
Comment
Share
